OBIO marks $1bn funding milestone for Canadian health tech ventures

Life sciences and technology companies supported by the OBIO's CAAP have collectively raised more than $1bn in capital. The initiative is designed to help post-seed health science enterprises secure investment, form corporate partnerships. OBIO delivers infrastructure, advocacy, and strategic programming across the medtech, digital health, therapeutics, and diagnostic fields. Credit: Gorodenkoff/Shutterstock.com. Life sciences and technology companies supported by the Ontario Bioscience Innovation Organization’s (OBIO) Capital Access Advisory Program (CAAP) have collectively raised more than C$1bn ($704.7m) in capital. The initiative is supported by the Government of Canada through the Federal Economic Development Agency for Southern Ontario. LOA and PTSR Model…

Salong Debbarma · 2026-09-30

Life sciences and technology companies supported by the OBIO's CAAP have collectively raised more than $1bn in capital.

Source: Pharmaceutical Technology